Ajanta Pharma Profit & Loss Annual

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01049 | Sector: Biotechnology & Drugs
2,646.05 -2.80 (-0.11%)Updated : 15 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 3,519.643,156.083,062.042,533.12
Other Net 4.143.596.1515.29
Diluted Weighted Average Shares 12.5212.6012.8112.97
Gain( Loss)on Saleof Assets -0.60-3.49-6.19-3.87
Depreciation/ Amortization 144.11135.40130.31124.82
Operating Income 1,128.461,052.63680.60807.87
Net Income 920.39816.17587.98712.69
Income Availableto Com Excl Extra Ord 920.39816.17587.98712.68
Other Operating Expenses Total 62.1746.9540.1335.39
Net Income Before Taxes 1,189.161,113.93745.25909.48
Net Income After Taxes 920.39816.17587.98712.69
Income Availableto Com Incl Extra Ord 920.39816.17587.98712.68
Costof Revenue Total 1,127.151,115.321,116.73886.72
Gross Profit 3,520.953,093.392,625.912,454.27
Interest Inc( Exp) Net- Non- Op Total 57.1661.2064.6990.19
Diluted Net Income 920.39816.17587.98712.68
Provisionfor Income Taxes 268.77297.76157.27196.79
period Type ----
Net Income Before Extra Items 920.39816.17587.98712.69
Total Revenue 4,648.104,208.713,742.643,340.99
period Length 12.0012.0012.0012.00
Revenue 4,648.104,208.713,742.643,340.99
Selling/ General/ Admin Expenses Total 2,186.211,858.411,774.381,481.72
Diluted Normalized EPS 73.5664.9746.2755.44
Diluted EPS Excluding Extra Ord Items 73.5364.7745.8954.96
Interest Exp( Inc) Net- Operating Total -0.000.490.49
DPS- Common Stock Primary Issue -10.007.006.33
Total Adjustmentsto Net Income ----0.10
Unusual Expense( Income) ---3.98
*All figures in crores except per share values
Recommended For You
Trending Stocks
684.30+9.80(1.45%)
1,576.00-43.95 (-2.71%)
159.45-0.90 (-0.56%)